Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study.
Diagnosis
HIV
In-hospital
Mortality
Sierra Leone
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
21 Oct 2019
21 Oct 2019
Historique:
received:
18
01
2019
accepted:
12
09
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
4
1
2020
Statut:
epublish
Résumé
HIV infection is a growing public health problem in Sierra Leone and the wider West Africa region. The countrywide HIV prevalence was estimated at 1.7% (67,000 people), with less than 30% receiving life-saving ART in 2016. Thus, HIV-infected patients tend to present to health facilities late, with high mortality risk. We conducted a prospective study of HIV inpatients aged ≥15 years at Connaught Hospital in Freetown-the main referral hospital in Sierra Leone-from July through September 2017, to assess associated factors and predictors of HIV-related mortality. One hundred seventy-three HIV inpatients were included, accounting for 14.2% (173/1221) of all hospital admissions during the study period. The majority were female (59.5%, 70/173), median age was 34 years, with 51.4% (89/173) of them diagnosed with HIV infection for the first time during the current hospitalization. The most common admitting diagnoses were anemia (48%, 84/173), tuberculosis (24.3%, 42/173), pneumonia (17.3%, 30/173) and diarrheal illness (15.0%, 26/173). CD4 count was obtained in 64.7% (112/173) of patients, with median value of 87 cells/μL (IQR 25-266), and was further staged as severe immunosuppression: CD4 < 100 cells/μL (50%, 56/112); AIDS: CD4 < 200 cells/μL (69.6%, 78/112); and late-stage HIV disease: CD4 < 350 cells/μL (83%, 93/112). Fifty-two patients (30.1%, 52/173) died during hospitalization, 23% (12/52) of them within the first week. The leading causes of death were anemia (23.1%, 12/52), pneumonia (19.2%, 10/52), diarrheal illness (15.4%, 8/52) and tuberculosis (13.6%, 7/52). Neurological symptoms, i.e., loss of consciousness (p = 0.04) and focal limb weakness (p = 0.04); alcohol use (p = 0.01); jaundice (p = 0.02); cerebral toxoplasmosis (p = 0.01); and tuberculosis (p = 0.04) were significantly associated with mortality; however, only jaundice (AOR 0.11, 95% CI [0.02-0.65]; p = 0.01) emerged as an independent predictor of mortality. HIV-infected patients account for a substantial proportion of admissions at Connaught Hospital, with a high morbidity and in-hospital mortality burden. These findings necessitate the implementation of specific measures to enhance early HIV diagnosis and expand treatment access to all HIV-infected patients in Sierra Leone.
Sections du résumé
BACKGROUND
BACKGROUND
HIV infection is a growing public health problem in Sierra Leone and the wider West Africa region. The countrywide HIV prevalence was estimated at 1.7% (67,000 people), with less than 30% receiving life-saving ART in 2016. Thus, HIV-infected patients tend to present to health facilities late, with high mortality risk.
METHODS
METHODS
We conducted a prospective study of HIV inpatients aged ≥15 years at Connaught Hospital in Freetown-the main referral hospital in Sierra Leone-from July through September 2017, to assess associated factors and predictors of HIV-related mortality.
RESULTS
RESULTS
One hundred seventy-three HIV inpatients were included, accounting for 14.2% (173/1221) of all hospital admissions during the study period. The majority were female (59.5%, 70/173), median age was 34 years, with 51.4% (89/173) of them diagnosed with HIV infection for the first time during the current hospitalization. The most common admitting diagnoses were anemia (48%, 84/173), tuberculosis (24.3%, 42/173), pneumonia (17.3%, 30/173) and diarrheal illness (15.0%, 26/173). CD4 count was obtained in 64.7% (112/173) of patients, with median value of 87 cells/μL (IQR 25-266), and was further staged as severe immunosuppression: CD4 < 100 cells/μL (50%, 56/112); AIDS: CD4 < 200 cells/μL (69.6%, 78/112); and late-stage HIV disease: CD4 < 350 cells/μL (83%, 93/112). Fifty-two patients (30.1%, 52/173) died during hospitalization, 23% (12/52) of them within the first week. The leading causes of death were anemia (23.1%, 12/52), pneumonia (19.2%, 10/52), diarrheal illness (15.4%, 8/52) and tuberculosis (13.6%, 7/52). Neurological symptoms, i.e., loss of consciousness (p = 0.04) and focal limb weakness (p = 0.04); alcohol use (p = 0.01); jaundice (p = 0.02); cerebral toxoplasmosis (p = 0.01); and tuberculosis (p = 0.04) were significantly associated with mortality; however, only jaundice (AOR 0.11, 95% CI [0.02-0.65]; p = 0.01) emerged as an independent predictor of mortality.
CONCLUSION
CONCLUSIONS
HIV-infected patients account for a substantial proportion of admissions at Connaught Hospital, with a high morbidity and in-hospital mortality burden. These findings necessitate the implementation of specific measures to enhance early HIV diagnosis and expand treatment access to all HIV-infected patients in Sierra Leone.
Identifiants
pubmed: 31638941
doi: 10.1186/s12889-019-7614-3
pii: 10.1186/s12889-019-7614-3
pmc: PMC6805411
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1320Subventions
Organisme : University Hospitals Cleveland Medical Center/Roe Green Travel Medicine Award 2019
ID : N/A
Références
Clin Infect Dis. 2004 Jul 1;39(1):129-32
pubmed: 15206064
Lancet. 2002 Dec 14;360(9349):1921-6
pubmed: 12493258
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):219-25
pubmed: 16186741
Lancet Infect Dis. 2014 Apr;14(4):281-90
pubmed: 24602844
AIDS. 2009 Sep 10;23(14):1881-9
pubmed: 19550291
Medicine (Baltimore). 2016 Apr;95(14):e3205
pubmed: 27057848
Afr Health Sci. 2008 Mar;8(1):8-12
pubmed: 19357726
N Engl J Med. 1991 Jun 6;324(23):1644-50
pubmed: 2030721
Chest. 1991 Jan;99(1):123-7
pubmed: 1984941
J Clin Oncol. 2019 Feb 1;37(4):296-304
pubmed: 30562130
PLoS One. 2016 May 11;11(5):e0154000
pubmed: 27166955
Clin Infect Dis. 2004 May 15;38(10):1454-63
pubmed: 15156485
AIDS Rev. 2018;20(3):174-175
pubmed: 30264829
J Antimicrob Chemother. 2019 Jul 1;74(7):2024-2029
pubmed: 30989237
AIDS. 2007 Jun 19;21(10):1301-8
pubmed: 17545706
Pan Afr Med J. 2017 May 18;27:48
pubmed: 28819470
AIDS. 1999 May 28;13(8):943-50
pubmed: 10371175
BMC Infect Dis. 2018 Jan 30;18(1):59
pubmed: 29378523
Open Forum Infect Dis. 2017 Jul 23;4(3):ofx156
pubmed: 28959700
Hepatology. 1996 Apr;23(4):728-33
pubmed: 8666325
Am J Trop Med Hyg. 2019 Jun;100(6):1521-1524
pubmed: 30938283
AIDS. 1992 Jun;6(6):571-4
pubmed: 1388879
AIDS Res Treat. 2012;2012:940580
pubmed: 23019521
J Int AIDS Soc. 2014 Apr 07;17:18797
pubmed: 24713375
Med Care. 2010 Dec;48(12):1071-9
pubmed: 21063228
Crit Care Med. 2016 Mar;44(3):e113-21
pubmed: 26901559
Pan Afr Med J. 2016 Sep 29;25:40
pubmed: 28154729
AIDS. 2008 Oct 1;22(15):1897-908
pubmed: 18784453
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S126-S131
pubmed: 29514239
AIDS Rev. 2018 Apr-Jun;20(2):104-113
pubmed: 29938704
Open Forum Infect Dis. 2018 Aug 23;5(9):ofy208
pubmed: 30191158